Latest News

Early initiation of rhythm control therapy is associated with clinical benefit in patients with heart failure and recently diagnosed atrial fibrillation. This was shown in a subgroup analysis of the EAST – AFNET 4 study population. The new findings were presented by Dr. Andreas...

Read more

An inhibitor of a fat-degrading protein can protect against heart failure. Researchers at the German Centre for Cardiovascular Research (DZHK) at the Charité – Universitätsmedizin Berlin were able to show this in mice. It is remarkable that the inhibitor does not act directly in...

Read more

Scientists at Mainz University Medical Center have discovered a previously unknown mechanism that influences the function of blood vessels: If a certain protein is missing or is genetically altered, this leads to stress in the inner vessel wall, which in turn can cause...

Read more

Until recently, there were few options for predicting the course of myocarditis in children. Now a team of scientists in Berlin, led by Sabine Klaassen at the ECRC, have discovered genetic defects associated with the severity of the disease, as they report in "Circulation:...

Read more

At the beginning of the corona pandemic, there were indications that patients with severe COVID-19 have a significantly increased risk of thrombosis. A specific protein that inhibits blood clotting could now be used in the drug treatment of corona patients.

Read more

Researchers have found a previously unknown cause of cardiac hypertrophy or the increase in heart muscle mass. Deviations in the genetic material cause ribosomes, which are the protein factories of heart cells, not to work effectively. The impaired protein production causes the...

Read more

Atherosclerosis is the main cause of stroke and heart attack. Previous treatments with medicines reduce the risk of cardiovascular disease in only some of the patients: Around 60 percent are still at risk. Researchers are focusing on the immune system to develop new therapies and...

Read more